Joe van Zwaren
Mr van Zwaren has over 30 years experience matching scientists and entrepreneurs to industry and investment. He is presently director at Haruv Technologies, and was VP at Leviathan Energy, and a R&D director at First Quality. He has also served as Director of Exact Sciences at the Ministry of Science and Technology, and was responsible for introducing both Internet and Internet-2 to Israel and along with many other national research programs.
Dr Hamutal Shahar
Dr. Shahar holds her PhD degree from the Ben-Gurion University of the Negev and has extensive experience in the field of clinical R&D. Currently serves as Clinical Director at Curesponse LTD. Previously, senior Manager of Clinical Development & Operations at Teva pharmaceuticals and CTM at BrainsWay.
Dr Yaron Suissa
Co-founder, Executive Advisor
Dr Suissa holds his degrees from the Hebrew University and led the pre-clinical research testing a new treatment for Pancreatic Neuro-Endocrine Tumors. He served as the head of R&D at TenCure, Manager of Business development and operations at NextGen-BioMed and the CSO at Molecular Detection Israel LTD. Dr Suissa is the former CEO of JLM-Biocity.
Dr Vitali Shilo
Vice President, Outreach
Dr Shilo, PhD from the department of Nephrology at the Hadassah Hospital, Hebrew University. The PhD project was focused on the development of a new treatment for kidney failure complications. He is an experienced R&D researcher and has worked for a cell-cure neuroscience company. His specializations are nephrology, stem cells, and endocrinology. Formerly an Operating Room supervising nurse and previously a branch manager of the Meuhedet health provider, Dr Shilo is currently a Project Manager at Stem Cell Medicine. Dr. Shilo is currently a Project Manager at Stem Cell Medicine.
Vice President, Logistics
Avigail Frij is a Senior Technical Writer and Marketing Communications professional, who has created technical documentation and marketing materials for a wide variety of technologies, including various bio medical related concerns. She has served on the board of the Jerusalem Business Networking Forum (JBNF) as a founding member and has been instrumental in creating JLM-BioCity to serve Jerusalem’s BioMeders.
Vice President, Public Relations
Dr. Deborah Amsallem holds degrees from Toulouse University of Sciences, (France) and Post-Doctorate from Technion, Haifa. She is currently R&D Senior Scientist and Process Engineer lead for Argaman technologies on development of new fiber and textile technologies for medical and military fields. She also served as QC supervisor & Project Lead at Omrix (Johnson & Johnson) and she was R&D and scale up responsible scientist at Bio-Lab.
Vice President, Operations
Yitz Goldglanz is a healthcare industry executive with extensive experience working in a top performing U.S. Hospital system. He holds an MBA is from Nova Southeastern University and is Lean Black Belt certified by the Institute of Industrial and Systems Engineers. His expertise is in working with all levels of organizational leadership and staff to strategically plan, build and deliver excellence to patients and providers. Currently, he also serves as a mentor, advisor, and coach to several U.S. and Israeli based health care focused startups and non-profits.
Vice President, Marketing
Sharon (Shifra) Feldman was an Executive Sales Representative for both J&J and Amgen Biotech and has 20+ years’ experience in pharma/biotech sales while living and working in Manhattan. In August of 2018, she, her husband, and their two younger daughters made aliyah to Ramat Beit Shemesh. Sharon recently landed her current role as Marketing and Communications Manager at Orgenesis Ltd., a start up biotech company in Rechovot. She has taught multiple Torah-based workshops on self-growth and has helped women achieve clarity in their personal and professional lives.